Testosterone cypionate is contraindicated in the presence of severeÂ renal, cardiac and hepatic disease, men with breast cancer and prostate cancer, venous thromboembolism, pregnant women, or women who may become pregnant breastfeeding women, hypersensitivity to any component of the formulation. The Endocrinology Society suggests that it may be judicious to avoid treatment with testosterone in men who have a history of myocardial infarction and stroke in the last six months.